The role of surgery in renal cell carcinoma;Die chirurgische therapie des nierenzellkarzinoms

Urologe - Ausgabe A

Volumn 38, Issue 5, 1999, Pages 452-459

  Staehler, G ^a   Brkovic, D ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Renal cell carcinoma; Surgical management

Indexed keywords

ADRENALECTOMY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; KIDNEY CARCINOMA; LYMPHADENECTOMY; NEPHRECTOMY; POSTOPERATIVE COMPLICATION; REVIEW; TREATMENT INDICATION;

ADULT; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; LYMPH NODE EXCISION; NEPHRECTOMY; PALLIATIVE CARE; POSTOPERATIVE COMPLICATIONS; SURVIVAL RATE;

EID: 0032866729     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001200050313     Document Type: Review

References (68)

1. Angervall L, Wahlquist L (1979) Follup and prognosis of renal carcinoma in a series operated by perifascial nephrectomy combined with adrenalctomy and retro-peritoneal lymphadenectomy. Eur Ural 4: 13-16
2. Badalament RA, Click RW, Wong GY, Gnecco C, Kreutzer E, Herr HW, Fair WR, Galicich JM (1990) Surgical treatment of brain metastases from renal cell carcinoma. Urology 36: 112-117
3. Branscheid D, Krysa S, Stoelben E, Bülzebruck H, Probst G, Vogt-Moykopf (1992) Chirurgische Therapie von Lungenmetasten beim Nierenzellkarzinom - Diagnostik, Strategie, Ergebnisse. Akt Ural 23: 106-112
4. Brkovic D, Riedasch G, Waldherr R, Röhl L, Staehler G (1994) Lokale Rezidive nach organerhaltender Nierentumorchirurgie. Urologe [A] 33: 104-109
5. Brkovic D, Dornseiff I, Staehler G (1997) The role of radical surgery for renal cell carcinoma with extension to the vena cava. J Urol 157 [4, Suppl]: 145
6. Brkovic D, Riedasch G, Staehler G (1997) Stellenwert der organerhaltenden Chirurgie beim Nierenkarzinom. Urologe [A] 36: 103-108
7. Brkovic D, Schneider P, Vogt-Moykopf I, Staehler G (1997) Die Bedeutung der Lungen-chirurgie beim pulmonal metastasierenden Nierenzellkarzinom. In: Staehler G (Hrsg) Nierentumoren. Springer, Berlin Heidelberg New York, S 131-140
8. Butler BP, Novick AC, Miller DP, Campbell SA, Licht MR (1995) Management of small unilateral renal cell carcinomas: radical versus nephron sparing surgery. Urology 45: 34-41
9. Campbell SC, Novick AC, Streem SB, Klein E, Licht M (1994) Complications of nephronsparing surgery for renal tumors. J Urol 151: 1177-1180
10. Cerfolio RJ, Allen MS, Deschamps C, Daly RC, Wallrichs SL, Trastek VF, Pairolero PC (1994) Pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 54: 339-344
11. Cheng WS, Farrow GM, Zincke (1991) The incidence of multicentricity in renal cell carcinoma. J Urol 146: 1221-1223
12. DeKernion JB, Ramming KP, Smith RB (1978) The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol 120: 148-152
13. DeKernion JB, Belldegrun A (1992) Renal tumors. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED jr. (eds) Campells urology. Saunders, Philadelphia London Torornto, pp 1053-1092
14. Eschwege P, Saussine C, Steichen G, Delepaul B, Drelon L, Jacqmin D (1996) Radical nephrectomy for renal cell carcinoma 30 mm or less: long term followup results. J Urol 155: 1196-1199
15. Fallick ML, Me Dermott DF, LaRock D, Long JP, Atkins MB (1997) Nephrectomy before interleukin-2 therapy for patients with metastatic renal cell carcinoma. J Urol 158: 1691-1695
16. Figlin RA, Pierce WC, Kaboo R, Tso CL, Moldawer N, Gitlitz B, deKernion J, Belldegrun A (1997) Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8( + ) selected tumor infiltrating lymphocytes from primary tumor. J Urol 158: 740-745
17. Foley FE, Mulvaney WP, Richardson EJ, Victor I (1952) Radical nephrectomy for neoplasm. J Urol 68: 39-42
18. Fossa S, Jones M, Johnson P, Holdener E, Elson P, Ritchie A, Selby P (1995) Interferon-alpha and survival in renal cell cancer. Br J Urol 76: 286-290
19. Giberti C, Oneto F, Martorana G, Rovida S, Carmignani G (1997) Radical nephrectomy for renal cell carcinoma: long-term results and prognostic factors on series of 328 cases. Eur Urol 31: 40-48
20. Gill IS, McClannan BL, Kerbl K, Carbone JM, Wick M, Clayman RV (1994) Adrenal involvement from renal cell carcinoma: predictive value of computerized tomography. J Urol 152: 1082-1085
21. Giuliani L, Martorana G, Giberti C, Pesatore D, Magnani G (1983) Results of radical nephrectomy with extensive lymphadenectomy for renal cell carcinoma. J Ural 130: 664-668
22. Giuliani L, Giberti C, Martorana G, Rovida S (1990) Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors. J Ural 143: 468-474
23. Golimbu M, Joshi P, Sperber A, Tessler A, Al-Askari S, Morales P (1986) Renal cell carcinom: survival and prognostic factors. Urology 27: 291-301
24. Guinan P, Stuhldreher D, Frank W, Rubenstein M (1997) Report of 337 patients with renal cell carcinoma emphasizing 110 with stage IV disease and review of literature. J Surg Oncol 64: 295-298
25. Hardy JD (1963) High ureteral injuries: management by autotransplantation of the kidney. J Am Med Assoc 184: 97-101
26. Hatcher PA, Anderson EE, Paulson DF, Carson CC, Robertson JE (1991) Surgical management and prognosis of renal cell carcinoma invading the vena cava. J Ural 145: 20-24
27. Hermanek P, Schrott KM (1990) Evaluation of the new nodes and metastases classification of renal cell carcinoma. J Ural 144: 238-241
28. Herrlinger A, Schrott KM, Schott G, Sigel A (1991) What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma? J Urol 146: 1224-1227
29. Höltl W, Aharinejad S (1994) Operativer Zugang zu den retrokruralen Lymphknoten. In: v. Hohenfellner R (Hrsg) Ausgewählte urologische Operationstechniken. Thieme, Stuttgart New York, 5. 189-5194
30. Kim B, Louie AC (1992) Surgical resection following Interleukin 2 therapy for metastatic renal cell carcinoma prolongs remission. Arch Surg 127: 1343-1347
31. Kinouchi T, Saiki S, Meguro N, Maeda O, Kuroda M, Usami M, Kotake T (1999) Impact of tumor size on the clinical outcomes of patients with Robson State I renal cell carcinoma. Cancer 85: 689-695
32. Lerner SE, Hawkins CA, Blute ML, Grabner A, Wollan PC, Eickholt JT, Zinke H (1996) Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Ural 155: 1868-1873
33. Licht MR, Novick AC (1993) Nephron-sparing surgery for renal cell carcinoma. J Ural 149: 1-7
34. Licht MR, Novick AC, Goormastic M (1994) Nephron-sparing surgery in incidental versus suspected renal cell carcinoma. J Ural 152: 39-42
35. Maldazys JD, Dekernion JB (1986) Prognostic factors in metastatic renal carcinoma. J Ural 136: 376-379
36. McNichols DW, Segura JW, DeWeerd JH (1981) Renal cell carcinoma: long term survival and late recurrence. J Ural 126:17-23
37. Montie JE, Stewat BH, Straffon RA, Banowsky LHW, Hewitt CB, Montague DK (1977) The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma. J Ural 117: 272-275
38. Morgan WR, Zincke H (1990) Progression and survival after renal conserving surgery of renal cell carcinoma: experience in 104 patients and extended follow up. J Ural 144: 857-858
39. Mostofi FK, Davis CJ (1986) Tumors and tumor-like lesions of the kidney. Curr Probl Cancer 10: 54-113
40. Mukamel E, Konichezky M, Engelstein D, Servadio C (1988) Incidental small renal tumors accompanying clinically overt renal cell carcinoma. J Ural 140: 22-24
41. Neves RJ, Zincke H (1987) Surgical treatment of renal cancer with vena cava extension. Br J Urol 59: 390-395
42. O'Dea MJ, Zincke H, Utz DC, Bernatz PE (1978) The treatment of renal cell carcinoma with solitary metastasis. J Urol 120: 540-542
43. Palmer PA, Vinke J, Philip T, Negrier S, Atzpodien J, Kirchner H, Oskam R, Franks CR (1992) Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2. Ann Oncol 3: 475-480
44. Petritsch PH, Rauchenwald M, Zechner O, Ludvik W, Pummer K, Urlesberger H, Eberle J, Joos H, Kaufman F, Kugler W, Desristoforo A, Dittel EE (1990) Results after organ-sparing surgery for renal cell carcinoma. Eur Ural 18: 84-87
45. Polascik TJ, Pound CR, Meng MV, Partin AW, Marshall FF (1995) Partial nephrectomy: technique, complications and pathological findings. J Ural 154: 1312-1318
46. Pomer S (1997) Das metastasierende Nierenzellkarzinom. In: Staehler G (Hrsg) Nierentumoren. Springer, Berlin Heidelberg New York, S 195-250
47. Provet J, Tessler A, Brown J, Golimbu M, Bosniak M, Morales P (1991) Partial nephrectomy for renal cell carcinoma: indications, results and implications. J Urol 145: 472-476
48. Rabinovitch RA, Zelefsky MJ, Gaynor JJ, Fuks Z (1994) Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy. J Clin Oncol 12: 206-212
49. Robertson CN, Linehan WM, Pass HI et al (1990) Preparative cytoreductive surgery in patients with metastatic renal cell carcinoma treated with adoptive immunotherapy with interleukin-2 or interleukin-2 plus lymphokine activated killer cells. J Urol 144: 614-618
50. Robey EL, Schellhammer PF (1986) The adrenal gland and renal cell carcinoma: is ipsilateral adrenalectomy a necessary component of radical nephrectomy? J Urol 101: 453-457
51. Robson CJ, Churchill BM, Anderson W (1969) The results of radical nephrectomy for renal cell carcinoma. J Ural 101: 297-301
52. Sagalowsky AI, Kadesky KT, Ewalt DM, Kennedy TJ (1994) Factors influencing adrenal metastasis in renal cell carcinoma. J Urol 151: 181-184
53. Sandock DS, Seftel AD, Resnick MI (1995) A new protocol for the follow up of renal cell carcinoma based on pathological stage. J Urol 154: 28-31
54. Skinner DG, Pritchett TR, Lieskovsky G, Boyd SD, Stiles QR (1989) Vena caval involvement by renal cell carcinoma - surgical resection provides meaningful long-term survival. Ann Surg 210: 387-392
55. Slaton JW, Balbay MD, Levy DA, Pisters LL, Nesbitt JC, Swanson DA, Dinney CP (1997) Nephrectomy and vena caval thrombectomy in patients with metastatic renal carcinoma. Urology 50: 673-677
56. Sosa RE, Muecke EC, Vaughan ED JR, McCarron JP (1984) Renal cell carcinoma extending to the inferior vena cava: the prognostic significance of the level of vena caval involvement. J Ural 132: 1079-1099
57. Staehler G, Liedl B, Kreuzer E, Sturm W, Schmiedt E (1987) Nierenkarzinom mit Cavazapfen: Einteilung, Operationsstrategie und Behandlungsergebnisse. Urologe [A] 26: 46-50
58. Staehler G, Liedl B (1988) Der Kavazapfen beim Nierenkarzinom: Operationstechnik und Ergebnisse. In: Staehler G (Hrsg) Das Nierenkarzinom. Springer, Berlin Heidelberg New York, S 76-84
59. Staehler G, Brkovic D (1997) Nierenkarzinome mit Vena cava Befall. Operative Strategien und Ergebnisse. Urologe [A] 36: 109-116
60. Steinbach F, Stöckle M, Hohenfellner R (1995) Current controversies in nephron-sparing surgery for renal cell carcinoma. World J Urol 13: 163-165
61. Störkel S, Thoenes W, Jacobi GH, Lippold R (1989) Prognostic parameters in renal cell carcinoma. Eur Urol 16: 416-422
62. Sugao H, Matsuda M, Nukano E, Seguchi T, Sonoda T (1991) Comparison of lumbar flank approach and transperitoneal approach for radical Nephrectomy. Urol Int 46: 43-45
63. Swanson DA, Borges PM (1983) Complications of transabdominal radical nephrectomy for renal cell carcinoma. J Urol 129: 704-707
64. Swierzewski DJ, Swierzewski MJ, Libertino JA (1994) Radical nephrectomy in patients with renal cell carcinoma with venous, vena caval and atrial extension. Am J Surg 168: 205-209
65. Van Poppel H, Claes H, Willemen P, Oyen R, Beart L (1991) Is there a place for conservative surgery in the treatment of renal carcinoma. Br J Urol 67: 129-133
66. Walther MM, Yang JC, Pass HI, Linehan WM, Rosenberg SA (1997) Cytoreductive surgery before high dose interleukin-2 based therapy in patients with metastatic renal cell carcinoma. J Urol 158: 1675-1678
67. Waters WB, Richie JP (1979) Aggressive surgical approach to renal cell carcinoma: review of 130 cases. J Urol 122: 306-309
68. Winter P, Miersch WD, Vogel J, Jaeger N (1990) On the necessity of adrenal extirpation combined radical nephrectomy. J Urol 144: 842-844